XAVIS grants 153,000 stock options to 13 employees at exercise price of 1,514 won (28% premium to current price); limited dilution risk
On May 29, 2026, XAVIS resolved through its board of directors to grant 153,000 common stock options (approximately 0.5% of total outstanding shares) to 13 employees.
The exercise price is 1,514 won, which is 28.3% higher than the current market price of 1,180 won, and the exercise period is from May 29, 2029 to May 28, 2032 (3 years).
The options are to be settled by issuing new shares. After this grant, total outstanding stock options increase to 514,000 shares (approximately 1.67% of outstanding shares).
The fair value of each stock option is 405.35 won, calculated using the binomial model, representing the option's intrinsic value, not the stock price.
The potential dilution from new share issuance is about 0.5% of current shares, but the exercise price above the market price limits immediate dilution risk.
[AI Comprehensive Analysis]This stock option grant is a routine compensation measure to incentivize long-term employee retention and performance. The grant size is small, and the exercise price exceeds the current stock price, limiting near-term dilution concerns. However, if the stock price rises, option exercises could increase share count, so investors should monitor exercise activity.